|
| 37709493 | Enhanced antitumour immunity following neoadjuvant chemoradiotherapy mediates a favourable prognosis in women with resected pancreatic cancer. | Gut | 2024 |
| 36759885 | Pervasiveness of HLA allele-specific expression loss across tumor types. | Genome Med | 2023 |
| 37588099 | Predictive signature of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer integrating mRNA expression, taxonomic subtypes, and clinicopathological features. | Front Oncol | 2023 |
| 37351909 | Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. | Cancer Epidemiol Biomarkers Prev | 2023 |
| 37210288 | Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights. | Eur Urol | 2023 |
| 37477495 | Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection. | Cancer Prev Res (Phila) | 2023 |
| 36817478 | Characterization of the tumor-infiltrating immune repertoire in muscle invasive bladder cancer. | Front Immunol | 2023 |
| 36807329 | New proposal to address mediation analysis interrogations by using genetic variants as instrumental variables. | Genet Epidemiol | 2023 |
| 34353775 | Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder Cancer. | Eur Urol Oncol | 2022 |
| 35536285 | Disinfection By-Products in Drinking Water and Bladder Cancer: Evaluation of Risk Modification by Common Genetic Polymorphisms in Two Case-Control Studies. | Environ Health Perspect | 2022 |
| 35398347 | Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study. | Gastroenterology | 2022 |
| 36477027 | Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A. | Nat Commun | 2022 |
| 36141212 | Making Sure That Orphan Incentives Tip the Right Way in Europe. | Healthcare (Basel) | 2022 |
| 36085102 | BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up. | Eur Urol | 2022 |
| 35069569 | A Pan-Cancer Analysis of Tumor-Infiltrating B Cell Repertoires. | Front Immunol | 2022 |
| 35260444 | A faecal microbiota signature with high specificity for pancreatic cancer. | Gut | 2022 |
| 32409590 | Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses. | Gut | 2021 |
| 33574088 | Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. | Cancer Res | 2021 |
| 33713162 | Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guérin immunotherapy for T1G3/HG bladder cancer. | World J Urol | 2021 |
| 33540773 | Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine. | Cancers (Basel) | 2021 |
| 33863885 | An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. | Nat Commun | 2021 |
| 33807330 | Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals <i>KRAS</i> Negativity and a Longer Overall Survival. | Cancers (Basel) | 2021 |
| 34527018 | Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk. | Front Genet | 2021 |
| 34431604 | UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better. | United European Gastroenterol J | 2021 |
| 34545020 | Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study. | Eur J Cancer Prev | 2021 |
| 34630409 | Tumor-Infiltrating B- and T-Cell Repertoire in Pancreatic Cancer Associated With Host and Tumor Features. | Front Immunol | 2021 |
| 34216462 | Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma. | Carcinogenesis | 2021 |
| 34147426 | Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients. | Actas Urol Esp (Engl Ed) | 2021 |
| 34359822 | Correction: Earl et al. Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals KRAS Negativity and a Longer Overall Survival. <i>Cancers</i> 2021, <i>13</i>, 1612. | Cancers (Basel) | 2021 |
| 34258619 | Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. | Am J Clin Nutr | 2021 |
| 33411965 | Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma. | Int J Cancer | 2021 |
| 32430337 | DNA Methylation-Derived Immune Cell Profiles, CpG Markers of Inflammation, and Pancreatic Cancer Risk. | Cancer Epidemiol Biomarkers Prev | 2020 |
| 33564664 | Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology. | Biomed Hub | 2020 |
| 32051190 | Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships. | Cancer Epidemiol Biomarkers Prev | 2020 |
| 31864026 | Diesel exhaust and bladder cancer risk by pathologic stage and grade subtypes. | Environ Int | 2020 |
| 32037144 | Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5. | Eur Urol | 2020 |
| 33188052 | Bratislava Statement: consensus recommendations for improving pancreatic cancer care. | ESMO Open | 2020 |
| 33301466 | A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study. | PLoS Med | 2020 |
| 33352812 | Incidence and Survival Trends of Pancreatic Cancer in Girona: Impact of the Change in Patient Care in the Last 25 Years. | Int J Environ Res Public Health | 2020 |
| 32635360 | Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant Chemotherapy. | Cancers (Basel) | 2020 |
| 32740166 | Gallbladder disease, cholecystectomy, and pancreatic cancer risk in the International Pancreatic Cancer Case-Control Consortium (PanC4). | Eur J Cancer Prev | 2020 |
| 32967863 | Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. | Cancer Epidemiol Biomarkers Prev | 2020 |
| 32682615 | FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?<sup>â¿ </sup>. | Eur Urol | 2020 |
| 32641412 | Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. | Cancer Res | 2020 |
| 32113160 | A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants. | EBioMedicine | 2020 |
| 32439797 | Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. | Cancer Epidemiol Biomarkers Prev | 2020 |
| 29158237 | Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations. | Gut | 2019 |
| 36157135 | CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis. | Bladder Cancer | 2019 |
| 30242024 | CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of <i>RB1</i> Status. | Clin Cancer Res | 2019 |
| 30229903 | Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case-control approaches. | Int J Cancer | 2019 |